Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Assets (2023 - 2025)

Historic Assets for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $252.4 million.

  • Tonix Pharmaceuticals Holding's Assets rose 16575.71% to $252.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $252.4 million, marking a year-over-year increase of 16575.71%. This contributed to the annual value of $162.9 million for FY2024, which is 545.98% up from last year.
  • As of Q3 2025, Tonix Pharmaceuticals Holding's Assets stood at $252.4 million, which was up 16575.71% from $187.4 million recorded in Q2 2025.
  • Tonix Pharmaceuticals Holding's 5-year Assets high stood at $252.4 million for Q3 2025, and its period low was $70.3 million during Q2 2024.
  • For the 3-year period, Tonix Pharmaceuticals Holding's Assets averaged around $157.2 million, with its median value being $159.7 million (2023).
  • As far as peak fluctuations go, Tonix Pharmaceuticals Holding's Assets plummeted by 5598.55% in 2024, and later soared by 16648.7% in 2025.
  • Quarter analysis of 3 years shows Tonix Pharmaceuticals Holding's Assets stood at $154.5 million in 2023, then increased by 5.46% to $162.9 million in 2024, then surged by 54.98% to $252.4 million in 2025.
  • Its Assets was $252.4 million in Q3 2025, compared to $187.4 million in Q2 2025 and $192.9 million in Q1 2025.